Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tetsu Hayashida

Showing results (21-30 of 84) with videos related to

Pageof 9
Sort By:
Breast Cancer (Tokyo, Japan)|February 22, 2021
A transposon screen identifies enhancement of NF-κB pathway as a mechanism of resistance to eribulinXiaozhong Teng, Tetsu Hayashida, Takeshi Murata, et al.
The Breast Journal|April 25, 2018
Clinicopathologic features of hormone-receptor-positive breast cancer patients with late recurrenceTakeshi Murata, Hiromitsu Jinno, Maiko Takahashi, et al.
Plos One|December 4, 2009
Induction of Foxp3-expressing regulatory T-cells by donor blood transfusion is required for tolerance to rat liver allograftsYuta Abe, Hidejiro Urakami, Dmitry Ostanin, et al.
International Journal of Surgery (London, England)|August 18, 2015
Technical feasibility of sentinel lymph node biopsy in patients with ipsilateral breast tumor recurrence and previous axillary surgeryAkiko Matsumoto, Hiromitsu Jinno, Tetsuya Nakamura, et al.
International Journal of Clinical Oncology|October 29, 2014
Prognostic implications of receptor discordance between primary and recurrent breast cancerAkiko Matsumoto, Hiromitsu Jinno, Takeshi Murata, et al.
Protein Engineering, Design & Selection : PEDS|June 28, 2005
Anti-angiogenic effect of an insertional fusion protein of human basic fibroblast growth factor and ribonuclease-1Tetsu Hayashida, Masakazu Ueda, Koichi Aiura, et al.
Pathology International|October 22, 2019
A first Japanese case of neuroendocrine prostate cancer accompanied by lung and brain metastasis with somatic and germline BRCA2 mutationTakeo Kosaka, Hiroshi Hongo, Eriko Aimono, et al.
Oncology Letters|July 30, 2020
Increased frequency of <i>ESR1</i> mutation in metastatic breast cancer by dosing selective estrogen receptor modulator followed by aromatase inhibitorKaoru Takeshima, Tetsu Hayashida, Hinako Maeda, et al.
Cancer Research|July 20, 2006
Loss of B-cell translocation gene-2 in estrogen receptor-positive breast carcinoma is associated with tumor grade and overexpression of cyclin d1 proteinHirofumi Kawakubo, Elena Brachtel, Tetsu Hayashida, et al.
Breast Cancer (Tokyo, Japan)|November 17, 2020
Predictors of invasive disease in patients preoperatively diagnosed with ductal carcinoma without stromal invasion, with breast magnetic resonance imaging (MRI) and ultrasound (US)Hinako Maeda, Tetsu Hayashida, Rurina Watanuki, et al.
Pageof 9

Showing results (21-30 of 84) with videos related to

Sort By:
Pageof 9
Breast Cancer (Tokyo, Japan)|February 22, 2021
A transposon screen identifies enhancement of NF-κB pathway as a mechanism of resistance to eribulinXiaozhong Teng, Tetsu Hayashida, Takeshi Murata, et al.
The Breast Journal|April 25, 2018
Clinicopathologic features of hormone-receptor-positive breast cancer patients with late recurrenceTakeshi Murata, Hiromitsu Jinno, Maiko Takahashi, et al.
Plos One|December 4, 2009
Induction of Foxp3-expressing regulatory T-cells by donor blood transfusion is required for tolerance to rat liver allograftsYuta Abe, Hidejiro Urakami, Dmitry Ostanin, et al.
International Journal of Surgery (London, England)|August 18, 2015
Technical feasibility of sentinel lymph node biopsy in patients with ipsilateral breast tumor recurrence and previous axillary surgeryAkiko Matsumoto, Hiromitsu Jinno, Tetsuya Nakamura, et al.
International Journal of Clinical Oncology|October 29, 2014
Prognostic implications of receptor discordance between primary and recurrent breast cancerAkiko Matsumoto, Hiromitsu Jinno, Takeshi Murata, et al.
Protein Engineering, Design & Selection : PEDS|June 28, 2005
Anti-angiogenic effect of an insertional fusion protein of human basic fibroblast growth factor and ribonuclease-1Tetsu Hayashida, Masakazu Ueda, Koichi Aiura, et al.
Pathology International|October 22, 2019
A first Japanese case of neuroendocrine prostate cancer accompanied by lung and brain metastasis with somatic and germline BRCA2 mutationTakeo Kosaka, Hiroshi Hongo, Eriko Aimono, et al.
Oncology Letters|July 30, 2020
Increased frequency of <i>ESR1</i> mutation in metastatic breast cancer by dosing selective estrogen receptor modulator followed by aromatase inhibitorKaoru Takeshima, Tetsu Hayashida, Hinako Maeda, et al.
Cancer Research|July 20, 2006
Loss of B-cell translocation gene-2 in estrogen receptor-positive breast carcinoma is associated with tumor grade and overexpression of cyclin d1 proteinHirofumi Kawakubo, Elena Brachtel, Tetsu Hayashida, et al.
Breast Cancer (Tokyo, Japan)|November 17, 2020
Predictors of invasive disease in patients preoperatively diagnosed with ductal carcinoma without stromal invasion, with breast magnetic resonance imaging (MRI) and ultrasound (US)Hinako Maeda, Tetsu Hayashida, Rurina Watanuki, et al.
Pageof 9